Launch of ACL BioMed Special Interest Group
2008-10-27
A new Special Interest Group of ACL (SIGBioMed) has been launched. It is dedicated to language processing in the biological, biomedical, and clinical domain. Dr. Ananiadou and Professor Tsujii are part of the organising commitee. The purpose of the BioMed SIG is to bring together researchers in NLP, bioinformatics, medical informatics, and computational biology, providing a venue (both wiki and workshop) for the promotion and dissemination of original research in this area.
| Previous item | Next item |
| Back to news summary page |
Featured News
- 1st Workshop on Misinformation Detection in the Era of LLMs - Presentation slides now available
- Prof. Ananiadou appointed Deputy Director of the Christabel Pankhurst Institute
- ELLIS Workshop on Misinformation Detection - Presentation slides now available
- Prof. Sophia Ananiadou accepted as an ELLIS fellow
- BioNLP 2025 and Shared Tasks accepted for co-location at ACL 2025
- Prof. Junichi Tsujii honoured as Person of Cultural Merit in Japan
Featured News Feed
Other News & Events
- AI for Research: How Can AI Disrupt the Research Process?
- CL4Health @ NAACL 2025 - Extended submission deadline - 04/02/2025
- Invited talk at the 15th Marbach Castle Drug-Drug Interaction Workshop
- Participation in panel at Cyber Greece 2024 Conference, Athens
- Shared Task on Financial Misinformation Detection at FinNLP-FNP-LLMFinLegal
Other News Feed
